MobiHealthNews

FDA gives Cue Health first EUA for at-home, OTC COVID-19 molecular testing

The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...
Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Business Wire

“Replace bogus PCR tests to avoid unnecessary Coronavirus lockdowns,” Urges Milford Molecular Diagnostics Director Dr. Sin Hang Lee

MILFORD, Conn.--(BUSINESS WIRE)--The current Coronavirus chaos is largely caused by phony PCR tests marketed as RT-qPCR assays, explained Dr. Sin Hang Lee, director of Milford, Connecticut-based ...
MobiHealthNews

Exclusive: 'STOP COVID-19' study will examine the accuracy of at-home tests

AI-enabled text-first virtual healthcare clinic Curai Health is partnering with UMass Chan Medical School to study how at-home antigen and molecular tests compare with lab PCR tests in detecting the ...
7News Miami

Early lab tests suggest new COVID-19 variant BA.2.86 may be less contagious and less immune-evasive than feared

(CNN) — Scientists around the world are fast-tracking lab experiments to try to understand the highly mutated BA.2.86 variant of the virus that causes COVID-19. Results just beginning to emerge are ...